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Abstract.  The M2 protein of influenza A  virus is a 
small integral membrane protein of 97 residues that is 
expressed on the surface of virus-infected cells. M2 
has an unusual structure as it lacks a  cleavable signal 
sequence yet contains an ectoplasmic amino-terminal 
domain of 23 residues, a  19 residue hydrophobic trans- 
membrane spanning segment, and a  cytoplasmic car- 
boxyl-terminal domain of 55  residues.  Oligonucleotide- 
mediated deletion mutagenesis was used to construct a 
series of M2 mutants lacking portions of the hydropho- 
bic  segment.  Membrane integration of the M2 protein 
was examined by in vitro translation of synthetic mRNA 
transcripts prepared using bacteriophage T7 RNA poly- 
merase.  After membrane integration, M2 was resistant to 
alkaline extraction and was converted to an Mr --~ 7,000 
membrane-protected fragment after digestion with 
trypsin. In vitro integration of M2 requires the cotrans- 
lational presence of the signal recognition particle. 
Deletion of as few as two residues from the hydropho- 
bic segment of M2 markedly decreases the efficiency 
of membrane integration, whereas deletion of six 
residues completely eliminates integration. M2 proteins 
containing deletions that eliminate stable membrane 
anchoring are apparently not recognized by signal rec- 
ognition particles, as these polypeptides remain sensi- 
tive to protease digestion, indicating that in addition 
they do not have a  functional signal sequence. These 
data thus indicate that the signal sequence that initiates 
membrane integration of M2 resides within the trans- 
membrane spanning segment of the polypeptide. 
T 
H~ insertion of most eukaryotic integral membrane 
proteins into the rough endoplasmic reticulum (ER) t 
is initiated by recognition of an ER-specific signal se- 
quence by the signal recognition particle (SRP). Substantial 
evidence has been obtained to indicate that SRP exists as a 
soluble cytoplasmic complex that can bind weakly to free 
ribosomes (49, 52) and bind with high affinity to the signal 
sequence of a  nascent secretory polypeptide as it emerges 
from the ribosome (23, 49, 55). High affinity  binding of SRP 
to the ribosome in many but not all cases induces an arrest 
of elongation (30, 31, 50),  which extends the time window 
available for the SRP-ribosome complex to interact with the 
SRP receptor or docking protein upon the surface of the ER 
membrane (15, 16) (for a mathematical analysis of SRP func- 
tion, see reference 37). However, data obtained using experi- 
mentally reconstituted subparticles  of SRP have demonstrated 
that an elongation arrest of translation is not an obligatory 
event in the translocation process (44).  Interaction of SRP 
1.  Abbreviations used  in  this paper:  ER,  endoplasmic reticulum;  HA, 
hemagglutinin;  K-RM,  salt-washed microsomes; RM, rough microsomes; 
SRP, signal recognition particle; TPCK, tosylamide  phenylmethyl  chloro- 
methyl ketone. 
with the SRP receptor causes SRP displacement from the 
ribosome with the concomitant release of the elongation ar- 
rest (13), thereby allowing the  initiation of nascent chain 
transport across the membrane bilayer.  In addition to the 
mechanism discussed above, a limited number of membrane 
proteins including cytochrome b5 and M13 preprocoat pro- 
tein have been shown to posttranslationally insert into micro- 
somal membranes in an SRP and SRP-receptor independent 
manner (2,  53). 
Integral membrane proteins can be classified into several 
categories based on their membrane topology (5, 12, 40, 54). 
Membrane proteins that span the bilayer a single time (bi- 
topic) can be subdivided into two classes based on the orien- 
tation of the polypeptide in the membrane. The most com- 
mon type (class I) contains a cleavable signal sequence that 
initiates translocation of the NH2-terminus of the protein 
into the lumen of the ER. A separate stop-transfer sequence 
eventually interrupts transport of the nascent chain to inte- 
grate the polypeptide in the bilayer with the COOH-terminal 
domain exposed to the cytoplasm. Well characterized exam- 
pies  of class  I  proteins  (12) include the  influenza virus 
hemagglutinin (HA),  vesicular-stomatitis virus G  protein, 
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II  integral membrane proteins  (12), e.g.,  influenza virus 
neuraminidase (NA), asialoglycoprotein receptor,  pammyxo- 
virus hemagglutinin-neuraminidase (HN), transferrin recep- 
tor (18, 20, 43), are integrated in the membrane in the oppo- 
site orientation, with an NH2-terminal cytoplasmic domain 
and  a  COOH-terminal  ectodomain.  The  transmembrane 
spanning sequence of class II proteins is typically located 
near the amino terminus of the polypeptide and serves as 
both a signal sequence and a membrane anchor. Polytopic in- 
tegral membrane proteins (class III) contain multiple trans- 
membrane spanning segments and are proposed to achieve 
their final topology in the membrane by expression of a se- 
ries of signal and stop-transfer sequences (3, 22). 
The  influenza A  virus  M2 protein  is an integral mem- 
brane protein (26, 29, 58) that cannot be classified in any of 
the above categories. The M2 protein has been shown to be 
integrated in the membrane with an extracellular domain of 
approximately 23 amino acid residues, a single hydrophobic 
domain of 19 residues, and a COOH-terminal domain of 55 
residues (29,  58).  To date, several  other polypeptides have 
been identified with a similar structure, including influenza 
B virus NB protein (57) and gp 74 V-erb B (17). Therefore, 
it was of interest to determine whether small integral mem- 
brane  proteins  with  this  topology use  the  SRP-mediated 
mechanism of membrane integration, or alternatively parti- 
tion directly into the lipid bilayer in a manner analogous to 
cytochrome b5 or M13 preprocoat protein. 
Materials and Methods 
Materials 
Canine pancreas rough microsomns (RM),  salt-washed microsomes (K- 
RM), and SRP were extracted and purified as described previously (13, 49). 
The unit definition of these reagents are those defined previously (49). The 
production and specificity of the M2  NH2-terminai monoclonal antibody 
(14C2)  will be described elsewhere (Zebedee, S.  L.,  and R.  A.  Lamb, 
manuscript in preparation) and was kindly made available by S. L. Zebedee. 
The WSN HA monoclonal antibody mix was kindly provided by Kathy Coe- 
lingh (National Institutes of Health). Oligonuclcotides were synthesized by 
the Northwestern University Bintechnology facility on an Applied Bio- 
systems (Foster City, CA) 38013 DNA synthesizer and were purified as de- 
scribed previously (35).  Rabbit anti-mouse IgG and tosylamide phenyl- 
methyl chloromethyl ketone (TPCK)-treated trypsin were purchased from 
Organon-Teknika,  Malvern, PA; protein A agarose from Boehringer-Mann- 
heim Biochemicals, Indianapolis, IN;  bacteriophage T7 DNA-dependent 
RNA  polymerase from  Bethesda Research  Laboratories,  Gaithersberg, 
MD;  7~G(53ppp(5')G  (sodium salt) and Sephadex G50  from Pharmacia 
Fine Chemicals, Piscataway,  NJ;  [3H]GTP  from ICN,  Irvine,  CA;  and 
[35S]cysteine from Amersham Corp., Arlington Heights, IL. 
Viruses, Cells, Radioisotopic Labeling 
lmmunoprecipitation,  and SDS-PAGE 
Influenza viruses (A/WSN/33 and A/UdonV72) were grown as described 
previously (25). CV-1 cells were maintained and infected as described previ- 
ously (24). Influenza virus-infected CV-I cells were labeled with [35S]cys- 
teine (100 I.tCi/ml) at 8-10 h postinfection in cysteine-deficient DME. Im- 
munoprecipitations were done in 1 ml of  0.15 M NaC1 RIPA buffer (27) with 
1-2  gl monoclonal antibody (anti-M2  or anti-HA as appropriate) in the 
presence of I mM phenylmethylsulfonyl fluoride (PMSF) and 100 KIU/ml 
aprotinin. Samples were incubated for 3 h at 4°C, 5 ttl rabbit anti-mouse 
IgG added, and the incubation continued for 30 rain before the addition of 
30 gl protein A-agarose and the slurry rocked at 40C for 1 h. The anti- 
gen-antibody-protein A complexes on the agarose beads were washed six 
times with 1.0 ml of  0.3 M NaC1RIPA buffer, twice with 1.0 ml 0.15 M NaCI 
RIPA buffer, and once with 1.0 ml 150 mM NaCI, 50 mM Tris-HC1, pH 7.4, 
5  mM EDTA.  The precipitated proteins were released from the protein 
A-agarose beads by boiling for 3 min in 50 Ixl of 2% SDS, 10% glycerol, 
5%  dithiothreitol (DTT),  62.5  mM Tris-HC1,  0.01% bromophenol blue. 
SDS-PAGE was done as described previously (28,  29). 
Preparation and Trypsinization of  Infected 
Cell Microsomes 
Microsomes were prepared according to the method of Adams and Rose (1). 
Influenza virus-infected CVI cells were labeled with [35S]eysteine as de- 
scribed above, and infected cell microsomes were isolated and subjected to 
digestion with 200  ttg/ml TPCK-treated trypsin as described previously 
(58). 
Isolation of mRNAs  from Influenza Virus-infected Cells 
RNA molecules containing polyadenylic acid were isolated from influenza 
virus-infected CV-1 cells at 10-12 h postinfection as described previously 
(34). After oligo(dT) cellulose selection, the mRNA was desalted by gel 
filtration from GS0 Sephadex, using H:O as the eluant. The RNA was eth- 
anol precipitated, dissolved in H20 at  1 laedgl, and stored at  -20°C. 
Site-specific Mutagenesis and Plasmid Construction 
The M2 eDNA described previously (58) was subcloned into the Barn HI 
site of the replicative form of bacteriophage M13mp8.  Deletion mutants 
were made using the oligonucleotide-directed mutagenesis procedure of 
Zoller and Smith (61). 24-mer mutagenic oligonucleotides were used, con- 
sisting of 12 nucleotides on either side of the required deletion. M2-spe- 
cific DNAs containing the deletions were inserted at the Barn HI site into 
pGEM-1 (Promaga Biotec, Madison, WI) and plasmids selected such that 
the M2 mRNA-sense RNA could be transcribed using the 1"7 promoter and 
T7 DNA-dependent RNA polymerase. The nucleotide sequence of the M2 
deletions was finally reconfirmed by direct sequencing of the plasmid DNA 
by the dideoxy chain-terminating method (41). 
In Vitro RNA Synthesis 
Plasmid DNAs were linearized at a  site beyond the T7 promoter and the 
M2 eDNA insert with Xba I.  Approximately 2  gg of linearized plasmid 
DNA were used as a template for RNA synthesis in a  100 ltl reaction con- 
taining 10 ~tCi [3H]GTP, 40 mM Tris-HCl pH 7.5,  6 mM MgCI2,  1 mM 
spermidine, 10 mM NaC1, 0.5 mM each of ATE CTP,  and UTE 150 I~M 
GTP, 150 gM ~pppG,  5 mM DTT, 40 U RNasin (Promega Biotec), and 
100 U T7 RNA polymemse. Samples were incubated for 60 rain at 37°C, 
a further 50 U T7 RNA polymerase were added, and incubation was con- 
tinued at 37°C for a further 60 min. The reaction was stopped with 10 p.l 
100 IzM EDTA and the DNA template digested with 2 U RNase-free DNase 
(RQ DNase; Promega Biotec) at 37°C for 10 rain. This reaction was stopped 
by the addition of 4 v.l 0.25 M EDTA at 4°C and the RNA extracted with 
a  1:1 mixture of phenol and cMoroform. The RNA was desalted on G50 
Sephadex, ethanol precipitated, dissolved in H20 at 5 gl/~tg, and stored at 
-20°C. The RNA yield was determined by measuring the incorporation of 
[3HIGI'P  into RNA, and the size of the RNA products was examined by 
electrophoresis on denaturing polyacrylamide gels. 
In Vitro Translation, Addition of  Membranes, and 
Protease Digestions 
All in vitro translations were done using wheat germ extracts essentially as 
described (27). For translation of infected cell poly(A+) RNA, the amount 
used was equivalent to the RNA extracted from one 10-cm diam tissue cul- 
ture plate per 100 gl reaction, and for translation of T7 RNA transcripts, 
1 0g RNA per 100 ~tl reaction was used. When necessary, dog pancreas RM 
and K-RM were added to one equivalent per 15 gl translation and SRP to 
30 U per 25 tad. When these additions were made, the salt concentrations 
in the translation reactions were adjusted such that the final concentration 
remained at 130 mM K + and 1.2 mM Mg  2+ with Nikoll (octaethylenegly- 
col-mono-N-dodecyl  ether; Nikko Chemical Corp., Tokyo, Japan) added at 
a final concentration of 0.002%  to stabilize the SRP. 
Treatment of membranes with protease, to examine for protected frag- 
ments, was done by dividing the translation reaction into three fractions. 
One fraction was left untreate~l and the other two were treated with 300 
tzg/ml TPCK-treated trypsin (preincubated at 27°C for 30 rain) in the pres- 
ence or absence of 1% Triton X-100 at 23°C for 60 rain in a final volume 
of 50 gl. In each case, the concentrations of K +, Mg  2+, and Nikkol were 
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of 60 KIU aprotinin, 1 mM PMSE and incubation at 4°C for l0 min. Sam- 
pies were then immunoprecipitated and analyzed by SDS-PAGE. 
Alkali Extraction of  Microsomes 
Alkali fractionation of microsomes was done basically as described previ- 
ously (35). Briefly, in vitro translation reactions were adjusted to a final vol- 
ume of 300  I.tl with 50 mM triethanolamine (pH 7.5),  11  lal  1 N  NaOH 
added, and the samples incubated at 4°C for 10 min. The samples were frac- 
tionated by layering on top of a 680 I~1 alkaline sucrose cushion (0.2 M su- 
crose, 30 mM Hepes, pH 11, 150 mM KOAc, 2.5 mM Mg[OAc]2) followed 
by centrifugation at 45,000 rpm at 4°C for 20 rain in a TL-100  table-top 
ultracentrifuge (Beckman Instruments, Inc., Palo Alto, CA) using a TLS-55 
swinging-bucket rotor. The supernatants were removed, an equal volume of 
20% TCA added, and the samples incubated at 4°C for 30 min. The pellets 
were resuspended in 100 I.tl of 1% SDS and precipitated with 100 I~1 20% 
TCA at 4°C for 30 min. Precipitated proteins from both the supernatant and 
pellet were recovered by centrifugation at 4°C for 15 rain in an Eppendorf 
microfuge. The pellets were washed with ethanol, vaccum dried, and solu- 
bilized at 37°C for 60 rain in 10 p.l of 0.1  M Tris-HC1  pH 8.9,  1% SDS. 
The solubilized products were then immunoprecipitated before analysis by 
SDS-PAGE. 
Results 
In Vitro Synthesis of M2 and Deletion Mutants of Mz 
To  facilitate experiments a  eDNA  to the M2 mRNA (58) 
was subcloned into pGEM-1, a plasmid containing the bacte- 
riophage T7  promoter (8),  such that M2 RNA transcripts 
could be synthesized using T7 RNA polymerase (see Mate- 
dais and Methods). In addition, a series of M2 mutants were 
constructed to examine the roles of the hydrophobic domain 
of M~ (see Fig. l). The deletion mutants lack between 2 and 
10 amino acids from the COOH-terminal region of the ME 
hydrophobic domain and were constructed by oligonucleo- 
tide-directed mutagenesis of the M2 eDNA in M13mp8 fol- 
lowed by reconstruction into pGEM-1.  M2-specific  recom- 
binant pGEM plasmids were digested with Xba I to linearize 
the DNA molecules and synthetic 7mGpppG-capped ME RNA 
was  synthesized in vitro using T7  RNA polymerase.  The 
RNAs were translated in wheat germ extracts and the prod- 
ucts were immunoprecipitated with a monoclonal antibody 
specific for the NH2-terminal region of M2 and analyzed by 
gel electrophoresis. As shown in Fig. 2, the mobility of the 
mutants (AM2)  correlates well with the number of amino 
acids deleted from the M2 protein (Mr =  15,000). Because 
there were no radioactive bands migrating above M2 in the 
polyacrylamide gel (Fig. 2), subsequent figures show only 
that portion of the gel between the dye front (Mr =  4,000) 
and M2 (Mr =  15,000). 
Integration of Mz into the ER Is SRP-dependent 
To examine the insertion of M2 into membranes in vitro, it 
was necessary to use a  protease protection assay because 
M2 lacks both a cleavable signal sequence and a consensus 
site that is used for asparagine-linked glycosylation  (58), and 
therefore no mobility shift could be expected.  When mi- 
crosomal vesicles containing M2  (isolated from influenza 
virus-infected cells) are treated with trypsin, the lumenal 
NHz-terminal region (Mr =  7000) is protected and the cyto- 
plasmic COOH-terminal region is protease sensitive (58). 
The protease-protected fragment (Mr = 7,000) from infected 
cell microsomes can be immunoprecipitated by the NH2- 
terminal ectodomain specific sera (Fig. 3, lane 2, asterisk). 
The detection of this fragment constitutes the major assay 
used in this study to demonstrate the in vitro insertion of M2 
protein into microsomal membranes.  Control experiments 
used  the  integral  membrane  protein  influenza virus  HA 
where a gel mobility shift due to addition of N-linked carbo- 
hydrate as well as protease protection were used as the assay 
for proper membrane integration. 
The M2 mRNAs were translated in vitro in the presence 
and absence of RM or K-RM (i.e., depleted of SRP) with or 
without exogenous SRP. Each in vitro translation reaction 
was divided into three parts: one part was left untreated, a 
second was treated with trypsin, and the third was treated 
with trypsin in the presence of 1% Triton X-100. The samples 
were immunoprecipitated with the M2 NH2-terminal-spe- 
cific serum, and the results of such an experiment are shown 
in Fig. 3. The primary M2-specific translation product (lane 
3) comigrates with M2 found in infected cell microsomes 
(lane 1). In the presence of added trypsin (lane 4) or trypsin 
plus  detergent  (lane  5),  the  vast  majority  of  M2  was 
digested.  A  small amount of a  polypeptide that migrates 
slightly  faster  than  the  NH2-terminal  protease-protected 
fragment from infected cell microsomes (lane 2) was also 
synthesized (lane 3).  This peptide, of unknown origin, is 
difficult to completely digest with trypsin even in the pres- 
ence of detergent. However, the presence of this polypeptide 
does not adversely affect interpretation of the results de- 
scribed here. In the presence of added RM, no mobility shift 
in M2 was observed as predicted based on the absence of a 
cleavable signal sequence or added carbohydrate (lane 6). 
Trypsin treatment of in vitro integrated M2 yielded a pro- 
teeter fragment (lane 7, asterisk) of identical mobility to the 
marker (lane 2) that is sensitive to digestion by trypsin in the 
presence of detergent (lane 8). The addition of K-RM does 
not  alter  the  mobility of M2  (lane  9),  and  no  trypsin- 
protected  fragment was  observed  (lane  10). Addition of 
K-RM and SRP (lane 12) yielded a NHE-terminal  specific 
fragment of M2 after trypsin digestion (lane 13) that has an 
identical mobility to the marker (lane 2), and was sensitive 
to trypsin digestion in the presence of detergent (lane 14). 
Thus, a comparison of the data in lanes 9 and 10 with those 
in lanes 12 and 13 strongly indicates that insertion of M2 
into membranes is mediated by a mechanism dependent on 
SRP. 
The  amount of trypsin-protected  fragment found after 
translation with RM (lane 7) was less than that with K-RM 
and SRP (lane 13) even though the same amount of RNA and 
microsomal membranes was used in each case. Transloca- 
tion of secretory proteins has also been shown to occur more 
efficiently with  SRP-supplemented K-RM  than  with  RM 
when using a wheat germ translation system (51),  whereas 
SRP  supplementation of either  RM  or  K-RM  using  the 
reticulocyte lysate system does not alter the translocation 
efficiency (30).  For experiments concerning SRP-dependent 
mechanisms,  the wheat germ translation system must be 
used because reticulocyte lysate contains endogenous SRP 
(30).  M2 protein contains three cysteine residues,  one of 
which located within the cytoplasmically exposed domain 
(29).  Protease digestion of integrated M2 should result in a 
one-third decrease in radioactivity recovered in the protease- 
protected  domain.  One  interpretation  of the  low  molar 
amount of the protected M2 fragment relative to the total 
amount of M2 synthesized (Fig. 3) would be that there is a 
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Figure  1.  Deletions  in  the  M2 
protein hydrophobic domain. The 
amino  acid  sequence  from resi- 
dues  16-52 of the M2 protein of 
stain A/Udorn/72  is shown in the 
single  letter  code  (data  derived 
from lamb et al. [28]). The boun- 
daries of the hydrophobic domain 
are  marked  by  vertical  dashed 
lines, and the amino acids deleted 
in  the  mutants  are  indicated  by 
solid horizontal bars. The A num- 
bers indicate the number of resi- 
dues deleted in the AM2 mutants. 
low efficiency of insertion of M2 into membranes. However, 
as  discussed  below,  the  most  likely  explanation  for  this 
finding is that the ME NH2-terminal specific monoclonal an- 
tibody has a lower affinity for the protected fragment than for 
intact M2. 
A control experiment was conducted to determine whether 
the RM, and K-RM with added SRP, were competent for in- 
sertion of integral membrane proteins and to show that the 
procedure for trypsin digestions did not rupture the vesicles. 
The mRNA encoding influenza virus HA (a class I integral 
membrane  glycoprotein)  was  translated  in  vitro  and  the 
glycosylation and  trypsin protection  monitored.  HA  as  a 
control is especially useful because although it is very well 
characterized in terms of synthesis and structure (56), it has 
not been formally shown that HA insertion into the ER re- 
quires SRP. 
Influenza A  virus infected-cell poly(A+)-containing  mRNA 
was translated in a wheat germ extract with the appropriate 
addition  of  pancreatic  microsomal  membranes  (RM  or 
K-RM) and SRP.  Samples were treated with trypsin or tryp- 
sin and detergent and then immunoprecipitated using a mix- 
ture of HA monoclonal antibodies. The results of this experi- 
ment  are  shown  in  Fig.  3  B.  In  the  absence  of  added 
microsomal  membranes,  only  unglycosylated  HA  (HAo) 
was synthesized (lane 3). When RM (lane 4) or K-RM with 
SRP (lane 6) were added, a significant proportion of HA was 
glycosylated as demonstrated by a  comigration of a  more 
slowly  migrating  polypeptide  (HA)  and  authentic  glyco- 
sylated HA (lane 1).  The proportion of HA0 converted to 
HA cannot be accurately quantitated from this experiment 
because the mixture of monoclonal antibodies precipitates 
HA  much  better  than  HA0.  However,  other  experiments 
using  either  a  polyclonal  antiserum  or  direct-analysis  of 
TCA-precipitated proteins indicate that 50-60%  of HA0 be- 
comes glycosylated (data  not  shown).  When  K-RM  were 
added to the translation in the absence of added SRP (lane 
5), a small amount of glycosylated HA could be observed, 
which is probably due to incomplete removal of SRP from 
Figure 2.  Synthesis in vitro of M2 translated  from in vitro tran- 
scribed RNAs. pGEM-1 plasmids containing wt M2 DNA or the 
AM2 DNAs were linearized with Xba I, and synthetic 7mGpppG- 
capped M2 mRNA and AM2 mRNAs were transcribed  by bacte- 
riophage T7 DNA-dependent RNA polymerase.  The RNAs were 
used to direct the synthesis of proteins in vitro using wheat germ 
extracts in the presence of [3~S]cysteine. The products were immu- 
noprecipitated  with  M2  NHTterminal-specific  monoclonal  anti- 
body. The precipitated proteins were analyzed by electrophoresis 
on  a  17.5% SDS-polyacrylamide  gel  containing  4  M  urea and 
visualized by fluorography. In this figure the entire gel is shown (the 
AM2 numbers mark the top and the lane numbers mark the bottom 
of the gel). In all subsequent figures only the section of the gel be- 
low the M2 band is shown. 
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into membranes is dependent on 
SRP.  (A)  Synthetic  7mGpppG- 
capped RNAs were translated in 
wheat germ extracts in the pres- 
ence (+) and absence (-) of mi- 
crosomal  membranes  and  SRP. 
The  samples  were  divided  into 
thirds,  with  one-third  as an un- 
treated control and the other two 
samples  treated  with  trypsin  in 
the presence  and absence of de- 
tergent as indicated at the top of 
each lane. A +  sign above a lane 
indicates the addition,  as appro- 
priate,  of  RM,  K-RM,  SRP, 
TRYP  (TPCK-treated  trypsin), 
and  DET  (Triton X-100). Reac- 
tion  products  were  immunopre- 
cipitated with M2 NHz-terminal- 
specific monoclonal antibody and 
analyzed by SDS-PAGE. Lane 1 
(also  marked  C),  control  lane 
showing marker M2 protein  im- 
munoprecipitated  from an influ- 
enza  A  virus  (strain,  A/Udorn/ 
72)  infected cell  lysate.  Lane  2 
(marked M), marker lane show- 
ing  the  NH2-terminal  fragment 
(Mr = 7,000) that is protected from 
trypsin digestion of microsomes 
isolated  from influenza A  virus 
(strain A/Udorn/72) infected cells. 
Fragments  that  comigrate  with 
this  marker are indicated  by an 
asterisk in other lanes.  (B) Poly- 
(A+)-containing  RNA molecules isolated from influenza A virus (strain A/WSN/33) infected cells were translated in wheat germ extracts 
under the conditions described  in Fig. 3 A. The translation products were immunoprecipitated with a mixture of HA-specific monoclonal 
antibodies and analyzed on an 8% SDS-polyacrylamide gel containing 4 M urea and visualized by fluorography. Lane I (also marked C), 
glycosylated HA immunoprecipitated from influenza A/WSN/33 infected-cell lysates. Lane 2, control translation with no added mRNA. 
The unglycosylated form of HA synthesized in vitro is designated HA0 and its position indicated by an arrow. RM, K-RM, SRP, TRYP, 
and DET are as indicated in the legend to Fig. 3 A. 
the salt-washed membranes. Trypsin treatment of the transla- 
tion products digested HA0 but not the ectodomain of HA 
(lanes 7-10), indicating that the microsomal vesicles are in- 
tact and  not damaged by the procedure.  (The extramicro- 
somal tail of HA is digested by trypsin, but the small shift 
in mobility cannot be detected on this gel system.) In the 
presence of trypsin and detergent, all HA-derived translation 
products were sensitive to proteolysis. Thus, these data indi- 
cate that the RM and K-RM +  SRP are competent for trans- 
location of proteins across membranes and that translocation 
of HA is dependent on an SRP-mediated mechanism. 
Deletion of  Amino Acids  from the 
COOH-Terminal Region of the 11/12 Signal-Anchor 
Domain Inhibits Signal Sequence Function 
The  above data  suggest  that  the  hydrophobic  membrane- 
spanning domain of M2 (residues 25-43) both targets Ms to 
the  ER  in  a  SRP-dependent  manner  and  acts  as  a  stop- 
transfer sequence to anchor Ms in the  membranes. Trans- 
membrane spanning segments of integral membrane proteins 
are typically both longer and more hydrophobic than are sig- 
nal  sequences (48).  To determine whether signal sequence 
function and membrane anchor function could be ascribed 
to specific sections of the M2 transmembrane segment, we 
constructed a  series of deletions ranging between 2 and  10 
residues  near the COOH-terminus of the  M2 hydrophobic 
domain. These seven deletion mutants (M2A) are indicated 
diagramatically in  Fig.  1,  and the  translation products are 
shown  in  Fig.  2  as  discussed  above.  Mutants  M2A2  and 
M2A2' have deletions of two residues (40 +  41 and 42  +  43, 
respectively). M2A4 has a deletion of four residues (38-41, 
inclusive) and M2A6 a  deletion of six residues  (36-41,  in- 
clusive).  Translation of M2A2,  A2',  and A4 mutant RNAs, 
in the presence of K-RM and SRP, yielded trypsin-protected 
NH2-terminal fragments (asterisk), whereas in the presence 
of K-RM alone,  the  AM2 proteins were all protease sensi- 
tive (compare Fig. 4 A, lanes 6 and 9, Fig 4 B, lanes 3 and 
6, and Fig. 4  C, lanes 6 and 9). In each case, the protected 
fragment was slightly smaller than the control wt M2 frag- 
ment and correlated directly with the size of the deletion in 
the hydrophobic domain.  Thus,  these data suggest that the 
15  uncharged  or  hydrophobic  residues  in  M2A4  are  suf- 
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brane  integration  properties  of 
AM2  proteins.  Synthetic  7mG- 
pppG-capped mRNAs of the M2 
deletion mutants were translated 
in  wheat  germ  extracts  in  the 
presence and absence of micro- 
somal membranes and SRP. Equal 
fractions were treated as a control 
or treated with trypsin in the pres- 
ence or absence of detergent as 
indicated at the top of each lane. 
RM,  K-RM,  SRP,  TRYP,  and 
DET are as indicated in the leg- 
end for Fig. 3 A. In each panel of 
this figure, the synthetic mRNA 
of the  deletion mutant that  was 
translated in vitro is identified at 
the top of the gel. In each panel, 
lane I  (also marked M) is a con- 
trol  containing the  M2  NH2-ter- 
minal fragment (M, =  7000) that 
is protected from trypsin digestion 
of microsomes isolated from in- 
fluenza A virus (strain A/Udorn/ 
72) infected cells. Fragments that 
are  specific  for  this  marker  are 
identified  by an asterisk. A-D show 
the  results  obtained  for  MzA2, 
A2', A4, and A6,  respectively. Figure  5.  Alkaline extraction of 
wt M2 and  AM2  proteins.  Syn- 
thetic  7mGpppG-cappod mRNAs 
of wt M2 and  M2  deletion mu- 
tants were translated in the pres- 
ence (+) and absence (-) of  K-RM 
+  SRE The translation products 
were alkaline extracted, separated 
into  pellet  (P)  and  supernatant 
(S)  fractions, TCA precipitated, 
resolubilized,  and  immunopre- 
cipitated with  M2 NH2-terminal 
monoclonal antibody as described 
in Materials  and  Methods. The 
products were analyzed  on a 17.5  % 
SDS-polyacrylamide gel contain- 
ing 4  M urea and visualized by 
fluorography. 
ficient for both SRP-mediated insertion into the membrane 
and  for anchoring of the protein.  Analysis of M2A6,  Ag, 
AS', and A10, which have deletions from 6 to 10 residues (see 
Fig.  1),  gave a  different result.  A  protease-protected frag- 
ment derived from M2A6,  AS,  AS', and  A10 was  not ob- 
served after translation in the presence of K-RM and SRP. 
In addition, no AM2 protein was found that was completely 
trypsin resistant,  as would be expected for a  soluble AM2 
molecule in the lumen of the microsomal vesicles. Thus, we 
could not obtain evidence indicative of  a functional signal se- 
quence and a nonfunctional anchor domain. Only the data 
for M2A6 are shown in Fig. 4 D, as it is representative of 
all the data obtained for the other larger deletion mutants. It 
should be noted that the apparent efficiency  of integration ob- 
served in the experiments shown in Fig. 4  cannot be com- 
pared with that in Fig. 3 as the experiments were performed 
at different times and with different batches of wheat germ 
extract. 
To examine further the insertion of the M2 deletion pro- 
teins into membranes, and to use an assay independent of the 
analysis of trypsin-protected fragments, alkaline extraction 
was used. This procedure is based on the criteria that upon 
alkali treatment (pHll) and centrifugation through an alka- 
line sucrose cushion, integral membrane proteins fractionate 
in the pellet while peripheral membrane proteins and soluble 
proteins are recovered in the supernatant (10, 14, 47). When 
translation of wt M2 mRNA was conducted in the absence 
of K-RM +  SRP, most of the M2 protein fractionated in the 
supernatant (Fig. 5). When K-RM  +  SRP were present at 
the beginning of the translation, a significant amount of M2 
fractionated in the pellet (Fig. 5). Although the level of  mem- 
brane integration of M2 varied somewhat between experi- 
ments,  the  percent  integration as  determined by alkaline 
fractionation was apparently greater than that indicated us- 
ing the protease-protection assay. Both assays rely upon im- 
munoprecipitation of M2 related polypeptides with a mono- 
clonal  antibody.  After alkali  fractionation,  the  intact  M2 
protein was immunoprecipitated from both the supernatant 
and pellet fractions. In contrast, in the trypsin-protection ex- 
periments,  intact  and  protease-digested  forms  of the  M2 
protein would need to be  immunoprecipitated with equal 
efficiency for a  direct comparison to be made.  Additional 
data suggest that the monodonal antibody cannot precipitate 
the M2 fragment protected in microsomes as efficiently as 
intact M2 (data not shown). 
When M2A2,  A2',  A4,  and  A6 proteins were analyzed 
by alkaline fractionation after translation in the presence of 
K-RM  +  SRP,  a proportion of the mutant polypeptide was 
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into membranes (Fig.  5).  However,  almost no M2A6  was 
found in the pellet fraction (Fig. 5).  These data for M2A6, 
coupled with the lack of any protease-protected fragment, 
suggest that the  13  uncharged or hydrophobic residues of 
M2A6 are insufficient to interact with SRP and provide a 
functional signal  to  initiate  membrane  insertion.  Hence, 
without the initial insertion, M2 cannot be anchored in the 
membrane. A reproducible lower efficiency of integration of 
all the M2 deletion proteins (M2A2,  A2', and A4) as com- 
pared with wt ME was observed (Fig. 5).  This finding sug- 
gests that even small  deletions within the  19  residue M2 
membrane-spanning  domain  have  a  deleterious  effect  on 
SRP-dependent targeting of M2 to the ER membrane. 
Discussion 
The M2 protein of influenza A virus is an example of a low 
molecular weight integral membrane protein that lacks  a 
cleavable signal sequence yet contains an ectoplasmic NH2- 
terminal domain and a COOH-terminal cytoplasmic domain. 
These structural features raised several intriguing questions 
concerning the mode of membrane integration of the M2 
protein. 
The initial question to be addressed was whether integra- 
tion  of M2  was  an  SRP-mediated  event,  or  was  instead 
promoted  by partitioning  of a  hydrophobic  insertion  se- 
quence into the membrane bilayer.  The data presented here 
indicate that integration of the M2 protein of influenza A vi- 
rus into the ER was strictly dependent upon the signal recog- 
nition particle.  High affinity binding of SRP to signal se- 
quences can induce a  complete arrest  (50)  or substantial 
decrease in the protein synthesis elongation rate (21), and in 
so doing effectively increase the time window for interaction 
of the SRP-ribosome complex with the ER membrane (37). 
Neither an arrest of translation nor a pronounced inhibition 
of M2 synthesis was detected in a  1-h translation containing 
SRP (data not shown).  A  lack of detectable inhibition of 
membrane protein synthesis by SRP is not unprecedented 
(2).  When in vitro translations of M2 protein were treated 
with puromycin before incubation with K-RM and SRP, no 
protease-protected fragments of the M2 protein could be de- 
tected (data not shown). However, a low level of posttransla- 
tional integration of  this low molecular weight protein cannot 
be totally excluded due to the detection limits that are im- 
plicit in the protease protection assay used in this study. 
Nonetheless, the data strongly suggest that integration of the 
M2  protein proceeds  by an  SRP-mediated cotranslational 
mechanism, in contrast to the low molecular weight poly- 
peptides discussed below. 
The minimum length of a  ribosome-bound polypeptide 
that could potentially be recognized by SRP is apparently 
equal to the length of the signal sequence plus the 40-50 
residues of a nascent chain which are buried in a protease, 
and  by  inference,  SRP-inaccessible  groove  in  the  large 
ribosomal subunit (4).  Because M2 protein has 23  amino 
acid residues that precede the hydrophobic transmembrane 
spanning sequence (29, 58), the majority of the 97 residue 
M2  protein  will  be  synthesized before  emergence  of the 
functional signal from the ribosome. Recently, translocation 
of several other low molecular weight polypeptides has been 
investigated to elucidate the mechanism of  transport for poly- 
peptides that fall near the minimal size range outlined above. 
Translocation of frog prepropeptide GLa, a 64 amino acid 
protein (19), has been shown to occur by a posttranslational 
SRP-independent mechanism (42).  An initial report propos- 
ing  an  SRP-independent posttranslational  mechanism  for 
translocation of the 70 residue polypeptide prepromelittin 
(33)  has been disputed (21). Clearly, further research will 
need to be done to determine the predominant mechanism of 
translocation and integration of low molecular weight poly- 
peptides. 
The  M2  protein  contains a  single hydrophobic domain 
that performs the dual role of acting as an SRP-dependent 
signal sequence and as a  stop-transfer sequence.  Previous 
data have shown that a single hydrophobic domain in a class 
II integral membrane protein is both necessary and sufficient 
to provide a signal sequence and a membrane anchor func- 
tion  (6,  46,  59).  Moreover,  stop-transfer sequences  from 
class I integral membrane proteins will provide a signal se- 
quence function when placed near the amino terminus of a 
reporter protein lacking a cleaved signal sequence (32,  59). 
Such  observations  clearly  reflect the  common  feature of 
hydrophobicity shared by signal sequences, stop-transfer se- 
quences, and signal-anchor sequences. Important structural 
differences between these sequences clearly exist, as inter- 
nally duplicated signal sequences do not function as stop- 
transfer sequences (11). The hydrophobic core of cleavable 
signal sequences is typically shorter than a transmembrane 
spanning segment of  an integral membrane protein (48), sug- 
gesting that the signal sequence function of the M2 hydro- 
phobic sequence could perhaps be experimentally located by 
deletion mutagenesis. 
With this goal in mind, we constructed a series of deletion 
mutants to regions within the M2 hydrophobic domain that 
provide signal and stop-transfer function. The data obtained 
using a  series of deletions constructed within the COOH- 
terminal region of the M2 hydrophobic domain demonstrate 
that  membrane  integration  of the  M2  protein  requires  a 
minimum of at least 15 residues of the 19 residue hydropho- 
bic domain. Substantial decreases in membrane integration 
of M2 were detected after deletion of as little as two amino 
acid residues from this region. Approximately 20 amino acid 
residues are required to span a lipid bilayer in an a-helical 
conformation (9).  Thus, deletion of two residues from the 
M2 hydrophobic segment will result in either a distortion of 
the or-helix or an insertion of two additional charged amino 
acid residues into the lipid bilayer.  Deletion analysis of the 
stop-transfer sequence of the vesicular stomatitis virus G 
protein (1), and experiments using artificially constructed 
apolar sequences (7), have both indicated a minimum length 
of approximately 12 residues for hydrophobic sequences that 
can interrupt translocation of a protein across a membrane 
bilayer.  Below  this  threshold  length  we  would  anticipate 
complete translocation of the M2 polypeptide provided that 
signal sequence function has been maintained. Translocation 
of hydrophobic sequences that do not meet such threshold 
values is a biologically relevant phenomenon for naturally 
occurring viral membrane fusion sequences (35).  To date, 
our deletion analysis of the M2 hydrophobic segment has 
not yielded a mutant that retains signal sequence function 
without also retaining stop-transfer function. In all cases, an 
increase in sensitivity to alkali extraction was accompanied 
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these results suggest that the signal and stop-transfer func- 
tions of the M2 hydrophobic sequence are inseparable, addi- 
tional deletion mutants within the transmembrane spanning 
sequence  will  need to be tested.  Extensive deletion muta- 
genesis  of  the  transmembrane  spanning  sequence  of  the 
asialoglycoprotein  receptor (a class II protein) has failed to 
identify a discrete region within that signal-anchor sequence, 
which retains signal sequence activity without anchoring the 
polypeptide in the membrane bilayer (45). 
The location or context of hydrophobic sequences within 
a polypeptide may modulate their activity to provide signal, 
stop-transfer,  or  signal-anchor  functions  (11, 32,  35,  60). 
Thus,  sequence  information  outside  the  hydrophobic  seg- 
ment of M2 may determine why this polypeptide is oriented 
in the membrane with a class I orientation rather  than the 
class II orientation,  which predominates among membrane 
proteins that lack cleavable  signal sequences. 
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